Hta & Market Access Scientific Advisor

Flatiron's mission is to learn from the experience of every cancer patient. Flatiron Health was founded in the United States but is working to expand its mission globally. We have established a small, fast-paced team focused on transforming the use of healthcare data in Europe and improving outcomes of European patients. Flatiron is looking to hire a specialist who will be responsible for driving a cross-functional effort aimed at powering Flatiron's Health Technology Assessment (HTA) and Market Access solutions as well as engaging and educating health authorities, Health Technology Assessment (HTA) bodies and related stakeholders in EU5 and other countries, on the use of real-world evidence (RWE), in particular RWE derived from Electronic Health Records (EHRs), in value assessment to inform local and regional access and reimbursement decisions. The position will be responsible for Flatiron's HTA engagement strategy and building relationships with HTA bodies, working closely with Flatiron's Regulatory Policy and International team. This job requires a strong understanding and background in ex-US (specifically, European) Market Access and HTA, ideally in Oncology. The person would need to demonstrate exceptional interpersonal, stakeholder management and relationship building skills. We are looking for an individual who is excited to work in a fast-paced environment, is motivated by solving complex problems and is willing to roll up their sleeves to get the job done. **Roles and Responsibilities** - Define a strategy for engaging and educating health authorities and HTA bodies in priority countries on the value of RWE and guidelines for use of RWE in HTAs, including building on Flatiron's existing collaboration with NICE in the UK - Lead a cross-functional program within Flatiron to execute on this strategy with clear short / medium term and longer term objectives (with representatives from Product, Clinical, Data Science, Regulatory Policy and client-facing teams) focused on increasing engagement and collaboration - Over time, create impactful collaboration opportunities with HTA bodies and health authorities to advance the guidelines and framework for the use of RWE in market access decisions - Leverage the work being done by Flatiron's Regulatory Policy team with health authorities (e.g. US FDA, MHRA, EMA) and other policy-making bodies to create meaningful dialogue with European health authorities **Requirements**: - Advanced degree preferred (MS or PhD in relevant area of study) - 5+ years experience in externally-facing roles in health tech, healthcare consulting or Biopharma with specific experience of health technology assessment and decision-making about market access and pricing. - Existing network within Health Authorities in countries such as Germany and the UK - Strong understanding of cost effectiveness / budget impact modeling and pricing negotiations as part of overall Access / Reimbursement decisions - Demonstrated leadership and management experience with success in bringing highly complex, cross-functional projects to completion - Experience developing external relationships and exceptional communication skills - Entrepreneurial spirit / "get it done" mentality with the ability to flex into / play different roles as needed to advance Flatiron's mission - High degree of comfort with ambiguity, able to quickly develop hypotheses with limited information and have a demonstrated ability to learn complex concepts quickly - Highly analytical, strategic thinker with the ability to translate between strategic business decisions and their implications - Open to travel for participation in events such as conferences, hearings and networking events **Bonus Points** - Fluency in German or other European languages - Specific domain expertise in an area relevant to Flatiron's products or operations: oncology, observational outcomes research, clinical research, real-world evidence - Specific experience working in Europe, particularly Germany - Understanding of marketing authorization approval pathways for drugs, biologics, advanced therapy medicinal products, etc. **About Flatiron** Flatiron Health is a leading healthcare technology company, headquartered in New York City, and focused on oncology. Flatiron was acquired for $1.9B in 2018, making it one of the largest technology exits in the industry, and remains an independent subsidiary of the largest oncology drug developer, the Roche Group. Flatiron is building a connected technology platform that enables the development of actionable insights that can help cancer care providers and researchers learn from every patient's experience. Our 1000+ employees represent a diverse group of leaders from across industries, including oncologists and nurses, data scientists, engineers, researchers and many more.